Edition:
United States

KemPharm Inc (KMPH.OQ)

KMPH.OQ on NASDAQ Stock Exchange Global Market

3.85USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,790
52-wk High
$5.35
52-wk Low
$2.45

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.69 December 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 6.42 24.20 0.00 43.91
Earnings (per share)
Quarter Ending Dec-17 4 -0.69 -0.65 -0.71 -0.78
Quarter Ending Mar-18 2 -0.67 -0.64 -0.69 --
Year Ending Dec-17 4 -2.71 -2.64 -2.89 -2.67
Year Ending Dec-18 4 -2.27 -1.59 -2.65 -1.55

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 6.42 6.42 6.42 6.05 43.91

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings